202 related articles for article (PubMed ID: 26310887)
21. Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.
Sarungbam J; Mehra R; Tomlins SA; Smith SC; Jayakumaran G; Al-Ahmadie H; Gopalan A; Sirintrapun SJ; Fine SW; Zhang Y; Amin MB; Reuter VE; Chen YB; Tickoo SK
Mod Pathol; 2019 May; 32(5):701-709. PubMed ID: 30622286
[TBL] [Abstract][Full Text] [Related]
22. Unsuspected Xp11 Translocation Renal Neoplasm Associated With Contralateral Clear Cell Carcinoma.
D'Antonio A; Addesso M; Nappi O; Zeppa P
Int J Surg Pathol; 2016 May; 24(3):248-52. PubMed ID: 26729550
[TBL] [Abstract][Full Text] [Related]
23. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study.
Kuroda N; Shiotsu T; Kawada C; Shuin T; Hes O; Michal M; Ohe C; Mikami S; Pan CC
Ann Diagn Pathol; 2011 Aug; 15(4):282-5. PubMed ID: 20952286
[TBL] [Abstract][Full Text] [Related]
24. A renal cell carcinoma with components of both chromophobe and papillary carcinoma.
Roehrl MH; Selig MK; Nielsen GP; Dal Cin P; Oliva E
Virchows Arch; 2007 Jan; 450(1):93-101. PubMed ID: 17124599
[TBL] [Abstract][Full Text] [Related]
25. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma.
Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O
Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022
[TBL] [Abstract][Full Text] [Related]
26. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
27. Sclerosing TFEB-rearrangement renal cell carcinoma: a recurring histologic pattern.
Williamson SR; Eble JN; Palanisamy N
Hum Pathol; 2017 Apr; 62():175-179. PubMed ID: 27864122
[TBL] [Abstract][Full Text] [Related]
28. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.
Yang XJ; Zhou M; Hes O; Shen S; Li R; Lopez J; Shah RB; Yang Y; Chuang ST; Lin F; Tretiakova MM; Kort EJ; Teh BT
Am J Surg Pathol; 2008 Feb; 32(2):177-87. PubMed ID: 18223319
[TBL] [Abstract][Full Text] [Related]
29. Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity.
Peckova K; Grossmann P; Bulimbasic S; Sperga M; Perez Montiel D; Daum O; Rotterova P; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Branzovsky J; Dubova M; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2014 Oct; 18(5):291-6. PubMed ID: 25175809
[TBL] [Abstract][Full Text] [Related]
30. Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study.
Al-Obaidy KI; Eble JN; Cheng L; Williamson SR; Sakr WA; Gupta N; Idrees MT; Grignon DJ
Am J Surg Pathol; 2019 Aug; 43(8):1099-1111. PubMed ID: 31135486
[TBL] [Abstract][Full Text] [Related]
31. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases.
Peckova K; Martinek P; Pivovarcikova K; Vanecek T; Alaghehbandan R; Prochazkova K; Montiel DP; Hora M; Skenderi F; Ulamec M; Rotterova P; Daum O; Ferda J; Davidson W; Ondic O; Dubova M; Michal M; Hes O
Ann Diagn Pathol; 2017 Feb; 26():23-30. PubMed ID: 28038707
[TBL] [Abstract][Full Text] [Related]
32. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases.
Alaghehbandan R; Ulamec M; Martinek P; Pivovarcikova K; Michalova K; Skenderi F; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2019 Feb; 38():80-86. PubMed ID: 30502717
[TBL] [Abstract][Full Text] [Related]
33. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
[TBL] [Abstract][Full Text] [Related]
34. Renal cell carcinoma with clear cell and papillary features.
Ross H; Martignoni G; Argani P
Arch Pathol Lab Med; 2012 Apr; 136(4):391-9. PubMed ID: 22458901
[TBL] [Abstract][Full Text] [Related]
35. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases.
Adam J; Couturier J; Molinié V; Vieillefond A; Sibony M
Histopathology; 2011 Jun; 58(7):1064-71. PubMed ID: 21707708
[TBL] [Abstract][Full Text] [Related]
36. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
[TBL] [Abstract][Full Text] [Related]
37. Interphase cytogenetics of multicentric renal cell tumours confirm associations of specific aberrations with defined cytomorphologies.
Amo-Takyi BK; Mittermayer C; Günther K; Handt S
Br J Cancer; 2000 Apr; 82(8):1407-14. PubMed ID: 10780519
[TBL] [Abstract][Full Text] [Related]
38. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
[TBL] [Abstract][Full Text] [Related]
40. Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity.
Sanfrancesco JM; Eble JN; Grignon DJ; Wang M; Zhang S; Sundaram CP; Idrees MT; Pili R; Kouba E; Cheng L
Mol Carcinog; 2017 Nov; 56(11):2527-2537. PubMed ID: 28667776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
